Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features

Published:2020-10 Issue:4 Volume:83 Page:1130-1143
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Ellis Samantha R.,Vierra Aren T.,Millsop Jillian W.,Lacouture Mario E.,Kiuru Maija

Funder

Dermatology Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

Dermatology

Reference135 articles.

1. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

2. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

3. Inhibitory B7-family molecules in the tumour microenvironment;Zou;Nat Rev Immunol,2008

4. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival;Curiel;Nat Med,2004

5. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers;Kono;Cancer Immunol Immunother,2006

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reacción psoriasiforme por nivolumab: reconociendo el espectro cutáneo de la inmunoterapia;Piel;2024-09

2. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors;World Journal of Clinical Oncology;2024-08-24

3. Omalizumab for management of hypersensitivity reactions to anticancer drugs;Internal Medicine Journal;2024-07-19

4. Disseminated nummular eczema following nivolumab treatment: Successful management with dupilumab;JEADV Clinical Practice;2024-07-08

5. Photoprotection: Current developments and controversies;Journal of the European Academy of Dermatology and Venereology;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3